Clozapine Use Pattern in the Province of Seville

Completed

• Conditions: Schizophrenia and Related Disorders

• Registration Number: NCT05083377
• Lead Sponsor: Fundación Pública Andaluza para la gestión de la Investigación en Sevilla

Brief Summary

CLOZAPINE USE PATTERN IN THE PROVINCE OF SEVILLE

Detailed Description

Subjects with a diagnosis of schizophrenia (F20 of ICD-10) under treatment with clozapine in the province of Seville. The use of clozapine, variability between centers and treatment modification will be identified.

Study Timeline

• Study Start: 2020-09-08
• Primary Completion: 2021-09-08
• Study Completion: 2021-09-08
• Status Verified: 2021-10
• Study First Submitted: 2021-10-06
• Study First Submitted QC: 2021-10-06
• Last Update Submitted: 2021-10-06
• Study First Posted: 2021-10-19
• Last Update Posted: 2021-10-19

Recruitment & Eligibility

• Status: COMPLETED
• Sex: All
• Target Recruitment: 600

Inclusion Criteria

Patients who have been prescribed (initially or regularly) clozapine during 2018, based on the casuistry provided by the Pharmacy service of the different hospitals.

Exclusion Criteria

• Parkinson's disease
• Dementia

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Identify the pattern of clozapine use in the province of Seville	year 2018	Identify the pattern of clozapine use in the province of Seville

Secondary Outcome Measures

Name	Time	Method
Analyze the changes in the course of the disease since the prescription of clozapine	year 2018	Analyze the changes in the course of the disease since the prescription of clozapine
Analyze the variability between centers or professionals	year 2018	Analyze the variability between centers or professionals

Trial Locations

Locations (1)

Hospital Universitario Virgen del Rocío; 🇪🇸 Sevilla, Spain